Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights
Provided By GlobeNewswire
Last update: Mar 31, 2025
Emrosi™ approved by FDA for the treatment of inflammatory lesions of rosacea in adults, with commercial launch underway; initial distribution ongoing and first prescriptions filled
Read more at globenewswire.comFORTRESS BIOTECH INC - FBIO 9 3/8 PERP
NASDAQ:FBIOP (8/15/2025, 8:18:30 PM)
7.88
+0.73 (+10.21%)
2.12
+0.16 (+8.16%)
Find more stocks in the Stock Screener
